Search

Your search keyword '"Frank, Stephen"' showing total 1,127 results

Search Constraints

Start Over You searched for: Author "Frank, Stephen" Remove constraint Author: "Frank, Stephen"
1,127 results on '"Frank, Stephen"'

Search Results

1. Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma

2. Advances in the Co-Simulation of Detailed Electrical and Whole-Building Energy Performance

6. Adoption Pathways for DC Power Distribution in Buildings †

7. Direct-DC Power in Buildings: Identifying the Best Applications Today for Tomorrow’s Building Sector

8. Deep-Learning-Based, Multi-Timescale Load Forecasting in Buildings: Opportunities and Challenges from Research to Deployment

9. Commercial Fault Detection and Diagnostics Tools: What They Offer, How They Differ, and What’s Still Needed

10. A Unified Architecture for Data-Driven Metadata Tagging of Building Automation Systems

11. The Impact of an Integrated Business Curriculum Program on Career Decision-Making Self-Efficacy

12. A Comprehensive Loss Model and Comparison of AC and DC Boost Converters

13. Endpoint Use Efficiency Comparison for AC and DC Power Distribution in Commercial Buildings

14. Direct-DC Power in Buildings: Identifying the Best Applications Today for Tomorrow’s Building Sector

15. A phase Ib trial of combined PKC and MEK inhibition with sotrastaurin and binimetinib in patients with metastatic uveal melanoma

16. The largest M dwarfs flares from ASAS-SN

17. A performance evaluation framework for building fault detection and diagnosis algorithms

18. Commercial Fault Detection and Diagnostics Tools: What They Offer, How They Differ, and What’s Still Needed

21. Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study

23. Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial

25. Spinning Straw into Gold: How State Education Agencies Can Transform Their Data to Improve Critical School Resource Decisions

26. Return on Investment in Education: A 'System-Strategy' Approach

29. Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

30. First Steps: What School Systems Can Do Right Now to Improve Teacher Compensation and Career Path

31. Fair Student Funding and Other Reforms: Baltimore's Plan for Equity, Empowerment, Accountability and Improvement

32. A Strategic Spending Review of Syracuse City School District

33. Time and Attention in Urban High Schools: Lessons for School Systems

34. District Spending in Small and Large High Schools: Lessons from Baltimore City, Boston, and Chicago. Executive Summary

35. District Spending in Small and Large High Schools: Lessons from Baltimore City, Boston, and Chicago

36. 'Strategic Review of FY06 District & School-Level Resources'. In Fulfillment of a Memorandum of Understanding between: The Los Angeles Unified School District (LAUSD) and The Unified Teachers of Los Angeles (UTLA). Phase II- Final ERS Report. An Executive Summary and Management Brief Series

37. 'Toward a Strategic Use of Resources in Saint Paul Public Schools': A Review of the SPPS FY2006 Spending Strategy with Recommendations

39. Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma

40. Direct-DC Power in Buildings: Identifying the Best Applications Today for Tomorrow’s Building Sector

44. Antiretroviral drug switches to zidovudine‐based regimens and loss to follow‐up during the first COVID‐19 lockdown in Bali, Indonesia

45. Anschluss- und Begleitkommunikationen zu literarischen Texten

48. Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma

Catalog

Books, media, physical & digital resources